OpenVSafe by OpenVAERS
Search V-safe

53B-67010-06005

3 vaccinations 8 coded responses 39 check-ins 8 free-text entries 5 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
919 / CA
Registered
2021-01-21
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-01-21
    Registered in v-safe
  2. 2021-01-21
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-21
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-28
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2021-02-04
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-11
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-11
    Health check-in — day 0, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  13. 2021-02-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  14. 2021-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Redness, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  16. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  17. 2021-02-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-18
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  20. 2021-02-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-18
    Survey response — day 35, dose 2
    MedDRA: Anxiety, Chills, Decreased appetite, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Withdrawal from gabapentine with anxiety, chills, lack of appetite
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-03-18
    Report sent to call center — day 35, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-03-25
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-05-13
    Survey response — 3 months, dose 2
    MedDRA: Asthenia, Diarrhoea, Pyrexia, Vomiting — Feeling: Good · Be unable to do your normal daily activities
    Free text: Vomiting, diarrhea and fever for two/three days. Very weak
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-08-12
    Survey response — 6 months, dose 2
    MedDRA: Axillary pain, Chest pain, Emergency care, Neck pain, Pain — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Chest pain left side radiating to neck and underarm. Seen in ER. Heart ok after tests. Referral to primary
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2021-08-12
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2021-08-15
  30. 2021-09-30
    Dose 3 — Pfizer-BioNTech
  31. 2021-09-30
    Health check-in — day 0, dose 3
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  32. 2021-10-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  33. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  37. 2021-10-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: Arthralgia — Feeling: Good · Muscle or body aches · Be unable to do your normal daily activities
    Free text: Joint pain can be overuse
    MedDRA releases: 2024-11 · check-in free text available
  38. 2021-10-07
    Health check-in — day 7, dose 3
    Feeling: Good · Muscle or body aches
    Adult check-in
  39. 2021-10-14
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-10-21
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  41. 2021-10-28
    Survey response — day 28, dose 3
    MedDRA: Cough, Respiratory tract congestion, Wheezing — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Congestion, wheezing, increased coughing
    MedDRA releases: 2024-11 · check-in free text available
  42. 2021-11-04
    Survey response — day 35, dose 3
    MedDRA: Cough, Respiratory tract congestion, Wheezing — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Cough wheezing congestion. On prednisone and antibiotic
    MedDRA releases: 2024-11 · check-in free text available
  43. 2021-11-04
    Report sent to call center — day 35, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  44. 2021-11-05
  45. 2021-11-10
  46. 2021-11-12
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  47. 2021-12-30
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  48. 2022-03-31
    Survey response — 6 months, dose 3
    MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Full body rash
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-03-31
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  50. 2022-04-04
  51. 2022-08-15
  52. 2022-09-30
    Survey response — 12 months, dose 3
    MedDRA: Chest discomfort, Cough, Productive cough, Sneezing, Wheezing — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Persistent productive cough with wheezing, sneezing and tight chest.
    MedDRA releases: 2024-11 · check-in free text available
  53. 2022-09-30
    Report sent to call center — 12 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  54. 2022-10-03
  55. 2022-10-03
  56. 2022-10-03
  57. 2022-10-03
  58. 2022-10-03

Vaccinations

DoseDateManufacturerCo-administered
12021-01-21Pfizer-BioNTech
22021-02-11Pfizer-BioNTech
32021-09-30Pfizer-BioNTech No

Call center

5 call center cases

5 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 5 — day 35, dose 2

2021-03-18

Symptoms: Withdrawal from gabapentine with anxiety, chills, lack of appetite

Release 8 — 3 months, dose 2

2021-05-13

Symptoms: Vomiting, diarrhea and fever for two/three days. Very weak

Release 9 — 6 months, dose 2

2021-08-12

Symptoms: Chest pain left side radiating to neck and underarm. Seen in ER. Heart ok after tests. Referral to primary

Release 10 — days 1–6 daily, dose 3

2021-10-06

Systemic reaction (other): Joint pain can be overuse

Release 10 — day 28, dose 3

2021-10-28

Symptoms: Congestion, wheezing, increased coughing

Release 10 — day 35, dose 3

2021-11-04

Symptoms: Cough wheezing congestion. On prednisone and antibiotic

Release 11 — 6 months, dose 3

2022-03-31

Symptoms: Full body rash

Release 12 — 12 months, dose 3

2022-09-30

Symptoms: Persistent productive cough with wheezing, sneezing and tight chest.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety ✓ ✓ ✓
SDAsthenia ✓ ✓ ✓
SDAxillary pain ✓ · ✓
SDChest discomfort · · ✓
SDChest pain ✓ · ✓
SDChills ✓ ✓ ✓
SDCough · · ✓
SDDecreased appetite ✓ ✓ ✓
SDDiarrhoea ✓ ✓ ✓
SDEmergency care ✓ · ✓
SDNeck pain ✓ · ✓
SDPain ✓ · ✓
SDPre-existing disease ✓ ✓ ✓
SDProductive cough · · ✓
SDPyrexia ✓ ✓ ✓
SDRash · · ✓
SDRespiratory tract congestion · · ✓
SDSneezing · · ✓
SDVomiting ✓ ✓ ✓
SDWheezing · · ✓
SROArthralgia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release